Clinical trial
Adjunctive Ziprasidone in Overweight and Obese Patients With Bipolar Disorder
NCT00472641 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Adjunctive Ziprasidone in Overweight and Obese Patients With Bipolar Disorder
- Lead sponsor
- Stanford University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2007
- Completion date
- December 31, 2009
- Enrollment
- 25 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.